Immune profiling of pediatric solid tumors
- 1 July 2020
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (7), 3391-3402
- https://doi.org/10.1172/jci137181
Abstract
Pediatric cancers, particularly high-risk solid tumors, urgently need effective and specific therapies. Their outlook has not appreciably improved in decades. Immunotherapies such as immune checkpoint inhibitors offer much promise, but most are only approved for use in adults. Though several hundred clinical trials have tested immune-based approaches in childhood cancers, few have been guided by biomarkers or clinical-grade assays developed to predict patient response and, ultimately, to help select those most likely to benefit. There is extensive evidence in adults to show that immune profiling has substantial predictive value, but few studies focus on childhood tumors, because of the relatively small disease population and restricted use of immune-based therapies. For instance, only one published study has retrospectively examined the immune profiles of pediatric brain tumors after immunotherapy. Furthermore, application and integration of advanced multiplex techniques has been extremely limited. Here, we review the current status of immune profiling of pediatric solid tumors, with emphasis on tumor types that represent enormous unmet clinical need, primarily in the context of immune checkpoint inhibitor therapy. Translating optimized and informative immune profiling into standard practice and access to personalized combination therapy will be critical if childhood cancers are to be treated effectively and affordably.This publication has 128 references indexed in Scilit:
- The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentJournal of Translational Medicine, 2013
- The Immune Microenvironment of Human Tumors: General Significance and Clinical ImpactCancer Microenvironment, 2012
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric AstrocytomasPLOS ONE, 2012
- Selection of Self-Reactive T Cells in the ThymusAnnual Review of Immunology, 2012
- Distinct signatures of the immune responses in low risk versus high risk neuroblastomaJournal of Translational Medicine, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005Cancer, 2009
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences of the United States of America, 2007
- Pediatric Cancers Are Infiltrated Predominantly by Macrophages and Contain a Paucity of Dendritic Cells: a Major Nosologic Difference with Adult TumorsClinical Cancer Research, 2006
- A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognitionThe Journal of Experimental Medicine, 2006